Corina Antal • UCSD Profiles (original) (raw)

  1. Integrative CRISPR Screening and RNA Analyses Discover an Essential Role for PUF60 Interactions with 3' Splice Sites in Cancer Progression. Cancer Res. 2025 Dec 18. Tankka AT, Zhang Y, Einstein JM, Zhou CJ, Pham VN, Naritomi JT, Nguyen GG, Mendez-Molina AN, Hu Z, Mizrahi O, Perelis M, Sarsam J, Tan FE, Kaufman DS, Yang J, Antal CE, Yeo GW. PMID: 41411621; PMCID: PMC12911328.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  2. C-spine mutations of protein kinase C and Akt as a novel generalizable approach to create stable pseudokinases. J Biol Chem. 2025 12; 301(12):110921. Hodapp SJ, Kao TH, Wu J, Balasuriya N, Antal CE, Taylor SS, Newton AC. PMID: 41207627; PMCID: PMC12721161.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  3. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression. Nat Commun. 2023 12 06; 14(1):7791. Liang G, Oh TG, Hah N, Tiriac H, Shi Y, Truitt ML, Antal CE, Atkins AR, Li Y, Fraser C, Ng S, Pinto AFM, Nelson DC, Estepa G, Bashi S, Banayo E, Dai Y, Liddle C, Yu RT, Hunter T, Engle DD, Han H, Von Hoff DD, Downes M, Evans RM. PMID: 38057326; PMCID: PMC10700526.
    View in: PubMed Mentions: 11 Fields:
    Translation:AnimalsCells
  4. A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. Nat Commun. 2023 09 06; 14(1):5195. Antal CE, Oh TG, Aigner S, Luo EC, Yee BA, Campos T, Tiriac H, Rothamel KL, Cheng Z, Jiao H, Wang A, Hah N, Lenkiewicz E, Lumibao JC, Truitt ML, Estepa G, Banayo E, Bashi S, Esparza E, Munoz RM, Diedrich JK, Sodir NM, Mueller JR, Fraser CR, Borazanci E, Propper D, Von Hoff DD, Liddle C, Yu RT, Atkins AR, Han H, Lowy AM, Barrett MT, Engle DD, Evan GI, Yeo GW, Downes M, Evans RM. PMID: 37673892; PMCID: PMC10482938.
    View in: PubMed Mentions: 19 Fields:
    Translation:AnimalsCells
  5. Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2021 Dec; 600(7889):E18. Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, Woo G, Fang L, Santisakultarm TP, Manor U, Xu R, Becerra CR, Borazanci E, Von Hoff DD, Grandgenett PM, Hollingsworth MA, Leblanc M, Umetsu SE, Collisson EA, Scadeng M, Lowy AM, Donahue TR, Reya T, Downes M, Evans RM, Wahl GM, Pawson T, Tian R, Hunter T. PMID: 34848876.
    View in: PubMed Mentions: 2 Fields:
  6. Protein kinase C fusion proteins are paradoxically loss of function in cancer. J Biol Chem. 2021 Jan-Jun; 296:100445. Van AN, Kunkel MT, Baffi TR, Lordén G, Antal CE, Banerjee S, Newton AC. PMID: 33617877; PMCID: PMC8008189.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansAnimalsCells
  7. Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts. Oncogenesis. 2020 Nov 09; 9(11):100. Noel P, Hussein S, Ng S, Antal CE, Lin W, Rodela E, Delgado P, Naveed S, Downes M, Lin Y, Evans RM, Von Hoff DD, Han H. PMID: 33168807; PMCID: PMC7653036.
    View in: PubMed Mentions: 37
  8. Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas. Cancer Res. 2020 10 15; 80(20):4324-4334. Lenkiewicz E, Malasi S, Hogenson TL, Flores LF, Barham W, Phillips WJ, Roesler AS, Chambers KR, Rajbhandari N, Hayashi A, Antal CE, Downes M, Grandgenett PM, Hollingsworth MA, Cridebring D, Xiong Y, Lee JH, Ye Z, Yan H, Hernandez MC, Leiting JL, Evans RM, Ordog T, Truty MJ, Borad MJ, Reya T, Von Hoff DD, Fernandez-Zapico ME, Barrett MT. PMID: 32928922; PMCID: PMC7906529.
    View in: PubMed Mentions: 36 Fields:
    Translation:HumansCells
  9. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2019 05; 569(7754):131-135. Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, Woo G, Fang L, Santisakultarm TP, Manor U, Xu R, Becerra CR, Borazanci E, Von Hoff DD, Grandgenett PM, Hollingsworth MA, Leblanc M, Umetsu SE, Collisson EA, Scadeng M, Lowy AM, Donahue TR, Reya T, Downes M, Evans RM, Wahl GM, Pawson T, Tian R, Hunter T. PMID: 30996350; PMCID: PMC6565370.
    View in: PubMed Mentions: 256 Fields:
    Translation:HumansAnimalsCells
  10. Protein kinase C mechanisms that contribute to cardiac remodelling. Clin Sci (Lond). 2016 09 01; 130(17):1499-510. Newton AC, Antal CE, Steinberg SF. PMID: 27433023; PMCID: PMC5024564.
    View in: PubMed Mentions: 25 Fields:
    Translation:HumansAnimalsCells
  11. Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease. Sci Signal. 2016 05 10; 9(427):ra47. Alfonso SI, Callender JA, Hooli B, Antal CE, Mullin K, Sherman MA, Lesné SE, Leitges M, Newton AC, Tanzi RE, Malinow R. PMID: 27165780; PMCID: PMC5154619.
    View in: PubMed Mentions: 59 Fields:
    Translation:HumansAnimalsCells
  12. Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII. Cell Rep. 2015 Aug 25; 12(8):1252-60. Antal CE, Callender JA, Kornev AP, Taylor SS, Newton AC. PMID: 26279568; PMCID: PMC4551583.
    View in: PubMed Mentions: 45 Fields:
    Translation:AnimalsCells
  13. Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor. Cell. 2015 Jan 29; 160(3):489-502. Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB, Hunter T, Brognard J, Newton AC. PMID: 25619690; PMCID: PMC4313737.
    View in: PubMed Mentions: 181 Fields:
    Translation:HumansAnimalsCells
  14. Tuning the signalling output of protein kinase C. Biochem Soc Trans. 2014 Dec; 42(6):1477-83. Antal CE, Newton AC. PMID: 25399557; PMCID: PMC5783555.
    View in: PubMed Mentions: 38 Fields:
    Translation:HumansCells
  15. Intramolecular conformational changes optimize protein kinase C signaling. Chem Biol. 2014 Apr 24; 21(4):459-469. Antal CE, Violin JD, Kunkel MT, Skovsø S, Newton AC. PMID: 24631122; PMCID: PMC4020788.
    View in: PubMed Mentions: 41 Fields:
    Translation:AnimalsCells
  16. Spatiotemporal dynamics of phosphorylation in lipid second messenger signaling. Mol Cell Proteomics. 2013 Dec; 12(12):3498-508. Antal CE, Newton AC. PMID: 23788531; PMCID: PMC3861703.
    View in: PubMed Mentions: 31 Fields:
    Translation:HumansAnimalsCells
  17. Electrostatic and hydrophobic interactions differentially tune membrane binding kinetics of the C2 domain of protein kinase Cα. J Biol Chem. 2013 Jun 07; 288(23):16905-16915. Scott AM, Antal CE, Newton AC. PMID: 23589289; PMCID: PMC3675623.
    View in: PubMed Mentions: 17 Fields:
    Translation:AnimalsCells
  18. Euphohelioscopin A is a PKC activator capable of inducing macrophage differentiation. Chem Biol. 2012 Aug 24; 19(8):994-1000. de Lichtervelde L, Antal CE, Boitano AE, Wang Y, Krastel P, Petersen F, Newton AC, Cooke MP, Schultz PG. PMID: 22921066; PMCID: PMC4079670.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansCells
  19. The effect of short-term hypoxic exposure on metabolic gene expression. J Exp Zool A Ecol Genet Physiol. 2012 Jan 01; 317(1):9-23. Everett MV, Antal CE, Crawford DL. PMID: 22021243; PMCID: PMC3237964.
    View in: PubMed Mentions: 14 Fields:
    Translation:AnimalsCells
  20. Active site inhibitors protect protein kinase C from dephosphorylation and stabilize its mature form. J Biol Chem. 2011 Aug 19; 286(33):28922-28930. Gould CM, Antal CE, Reyes G, Kunkel MT, Adams RA, Ziyar A, Riveros T, Newton AC. PMID: 21715334; PMCID: PMC3190699.
    View in: PubMed Mentions: 28 Fields:
    Translation:HumansAnimalsCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs